(R)-N-(4-(5-((2-((tert-butyldimethylsilyl)oxy)-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)pent-1-yn-1-yl)phenyl)-2,2,2-trifluoroacetamide → (R)-1-(4-(5-((2-((tert-butyldimethylsilyl)oxy)-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)pent-1-yn-1-yl)phenyl)-3-((1,6-diethyl-4-((tetrahydro-2H-pyran-4-yl)amino)-1H-pyrazolo[3,4-b]pyridin-5-yl)methyl)urea
反応式
[Si:1]([O:8][C@H:9]([C:30]1[CH:39]=[CH:38][C:37]([OH:40])=[C:36]2[C:31]=1[CH:32]=[CH:33][C:34](=[O:41])[NH:35]2)[CH2:10][NH:11]CCCC#CC1C=CC(NC(=O)C(F)(F)F)=CC=1)([C:4]([CH3:7])([CH3:6])[CH3:5])([CH3:3])[CH3:2].Br[CH2:43][CH2:44][CH2:45][C:46]#[C:47][C:48]1[CH:53]=[CH:52][C:51]([NH:54][C:55]([NH:57][CH2:58][C:59]2[C:60]([NH:72][CH:73]3[CH2:78][CH2:77][O:76][CH2:75][CH2:74]3)=[C:61]3[CH:69]=[N:68][N:67]([CH2:70][CH3:71])[C:62]3=[N:63][C:64]=2[CH2:65][CH3:66])=[O:56])=[CH:50][CH:49]=1>>[Si:1]([O:8][C@H:9]([C:30]1[CH:39]=[CH:38][C:37]([OH:40])=[C:36]2[C:31]=1[CH:32]=[CH:33][C:34](=[O:41])[NH:35]2)[CH2:10][NH:11][CH2:43][CH2:44][CH2:45][C:46]#[C:47][C:48]1[CH:53]=[CH:52][C:51]([NH:54][C:55]([NH:57][CH2:58][C:59]2[C:60]([NH:72][CH:73]3[CH2:74][CH2:75][O:76][CH2:77][CH2:78]3)=[C:61]3[CH:69]=[N:68][N:67]([CH2:70][CH3:71])[C:62]3=[N:63][C:64]=2[CH2:65][CH3:66])=[O:56])=[CH:50][CH:49]=1)([C:4]([CH3:7])([CH3:6])[CH3:5])([CH3:2])[CH3:3]参加物
3
反応物 2
HCID 58505275(R)-N-(4-(5-((2-((tert-butyldimethylsilyl)oxy)-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)pent-1-yn-1-yl)phenyl)-2,2,2-trifluoroacetamide
HCID 585052951-(4-(5-bromopent-1-yn-1-yl)phenyl)-3-((1,6-diethyl-4-((tetrahydro-2H-pyran-4-yl)amino)-1H-pyrazolo[3,4-b]pyridin-5-yl)methyl)urea生成物 1
実験手順
The title compound was prepared in a manner analogous to that described for Intermediate 37, using Intermediate 35 in place of Intermediate 26. ES/MS calcd. for C45H61N8O5Si+ 821.5. found m/z=821.6 (M+H)+.
出典と根拠
- ORDレコード
- ord-345e4582e21f463dbdb503e8dcef68b2
- 出典データセット
- uspto-grants-2013_02
- 特許番号
- US08367829B2
関連ノート
読み込み中…